Patients
bioTheranostics develops molecular diagnostic oncology tests that provide valuable information to help physicians identify more appropriate therapies for individual cancer patients.
These innovative tests provide important data on cancer origin and future cancer risk assessment, allowing your physician to be more informed when determining your therapy options.
Accurate cancer identification and risk assessment
CancerTYPE ID® provides molecular classification of uncertain or unknown cancers to guide physicians in determination of the primary cancer site and aid in the selection of appropriate therapies.
View the Patient Testimonial by clicking on the video below.
Breast Cancer IndexSM predicts breast cancer recurrence risk based on proprietary molecular biomarkers, resulting in more appropriate treatment decisions.
+1 (877) 886-6739 client services
